EMPAGLIFLOZIN — all Canadian products
9 DINs
7 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is EMPAGLIFLOZIN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02443937 | JARDIANCE | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | EMPAGLIFLOZIN 10 MG | Marketed | |
| 02443945 | JARDIANCE | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | EMPAGLIFLOZIN 25 MG | Marketed | |
| 02456575 | SYNJARDY | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | EMPAGLIFLOZIN 5 MG; METFORMIN HYDROCHLORIDE 500 MG | Marketed | |
| 02456583 | SYNJARDY | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | EMPAGLIFLOZIN 5 MG; METFORMIN HYDROCHLORIDE 850 MG | Marketed | |
| 02456591 | SYNJARDY | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | EMPAGLIFLOZIN 5 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02456613 | SYNJARDY | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | EMPAGLIFLOZIN 12.5 MG; METFORMIN HYDROCHLORIDE 850 MG | Marketed | |
| 02456621 | SYNJARDY | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | EMPAGLIFLOZIN 12.5 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed | |
| 02459752 | GLYXAMBI | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | EMPAGLIFLOZIN 10 MG; LINAGLIPTIN 5 MG | Cancelled Post Market | |
| 02459760 | GLYXAMBI | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet | Oral | EMPAGLIFLOZIN 25 MG; LINAGLIPTIN 5 MG | Cancelled Post Market |
Browse other molecules: